腾博会官网·[中国]-诚信为本,专业服务!

VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY CHIA TAI TIANQING UNDER THE SHARE INCENTIVE SCHEME

VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF "GADOTERIDOL INJECTION"

VOLUNTARY ANNOUNCEMENT - KRAS G12C INHIBITOR "GARSORASIB TABLET (D-1553)" INCLUDED IN THE BREAKTHROUGH THERAPEUTIC DESIGNATION PROCESS

VOLUNTARY ANNOUNCEMENT - PUBLICATION OF STUDY FINDINGS OF PHASE II CLINICAL TRIAL OF KRAS G12C INHIBITOR "GARSORASIB TABLET (D-1553)" IN THE LANCET RESPIRATORY MEDICINE

VOLUNTARY ANNOUNCEMENT - PRESENTATION OF POSITIVE CLINICAL DATA FROM PHASE 1 STUDY OF FS222 (CD137/PD-L1) AT THE 2024 ASCO

RETIREMENT OF EXECUTIVE DIRECTOR

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

ADJUSTMENT TO CONVERSION PRICE OF THE BONDS